Edwards Lifesciences (NYSE: EW) reported quarterly earnings of $0.58 per share which missed the analyst consensus estimate of $0.62 by 6.15 percent. This is a 1.69 percent decrease over earnings of $0.59 per share from the same period last year. The company reported quarterly sales of $1.570 billion which beat the analyst consensus estimate of $1.546 billion by 1.53 percent. This is a 13.28 percent increase over sales of $1.386 billion the same period last year.